Juno's trial gets stopped due to 3 deaths and the stock gets clipped 33%.
CLDX' PH III trial gets stopped despite performing consistent with several prior trials - no deaths, and Pts. living as long as 12 years - and it get crushed by 60% and remains dormant.
Meanwhile CLDX' former parent, MEDX, is now trumpeted as the "Acquisition Deal of the Decade" as achieved by BMY.
Sentiment: Strong Buy
....and, the VA is fighting paying for Old Vets involved in Mustard Gas experiments.......shameful.